National Healthcare, Corp. (NHC) and Tenet Health (THC) on Torvanta's measures: NHC grades higher on 0 of the 4 factor families and THC on 3.
| NHC | THC | |
|---|---|---|
| Value grade | C | A+ |
| Growth grade | C+ | B |
| Profitability grade | C+ | A- |
| Momentum grade | A- | A- |
| Market value | $3.8B | $21.5B |
| P/E (trailing) | 27.3x | 10.3x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $1.6B | $21.8B |
| Revenue growth (y/y) | +7% | +5% |
| Operating margin | 9.3% | 20.8% |
| Return on invested capital | 10.3% | 149.8% |
| Free-cash-flow yield | 3.9% | 14.0% |
| Total return, 1 year | +102.2% | +34.2% |
| Total return, 3 years | n/a | n/a |
Full NHC analysis · Full THC analysis
National Healthcare, Corp. (NHC) and Tenet Health (THC) on Torvanta's measures: NHC grades higher on 0 of the 4 factor families and THC on 3. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings NHC trades at 27.3x and THC at 10.3x; their value grades are C and A+ against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer